HemaSphere
(Jun 2022)
P792: CRISPR/CAS9-BASED MODEL OF HETEROZYGOUS CXCR4 WT/R334X MUTATION TO STUDY CELLULAR PHENOTYPES IN WHIM SYNDROME
- K. Zmajkovicova,
- S. Pawar,
- S. Maier-Munsa,
- A. Badarau,
- A. G. Taveras
Affiliations
- K. Zmajkovicova
- 1 X4 Pharmaceuticals (Austria) GmbH
- S. Pawar
- 1 X4 Pharmaceuticals (Austria) GmbH
- S. Maier-Munsa
- 1 X4 Pharmaceuticals (Austria) GmbH
- A. Badarau
- 2 Former Employee at X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria
- A. G. Taveras
- 3 X4 Pharmaceuticals, Boston, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000846052.61635.87
- Journal volume & issue
-
Vol. 6
pp.
687
– 688
WeChat QR code